Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy

被引:43
|
作者
Zhou, Li [1 ]
Rui, Jing-An [1 ]
Wang, Shao-Bin [1 ]
Chen, Shu-Guang [1 ]
Qu, Qiang [1 ]
Chi, Tian-Yi [1 ]
Wei, Xue [1 ]
Han, Kai [1 ]
Zhang, Ning [1 ]
Zhao, Hai-Tao [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing 100032, Peoples R China
关键词
D O I
10.1007/s00268-007-9029-z
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Radical major hepatectomy (RMH) has been suggested as one of main options for cure of large/advanced hepatocellular carcinoma (HCC). However, its operative risk remains high and its effectiveness is still controversial, especially for patients with liver cirrhosis. The present study aims to investigate short- and long-term outcomes and to identify prognostic factors for cirrhotic patients with HCC after RMH. Materials and Methods Prospectively collected clinicopathological data of 81 consecutive cirrhotic HCC patients who underwent RMH were reviewed retrospectively. The Kaplan-Meier method was adopted for evaluating long-term survival. Prognostic factors were identified by univariate and multivariate analyses. Results After RMH, perioperative mortality, overall morbidity, and life-threatening morbidity were 1.2%, 24.7%, and 12.3%, respectively. Overall and disease-free 5-year survival rates were 39.4% and 28.1%, respectively. Univariate analysis showed that presence of portal vein tumor thrombosis (PVTT) and satellite nodules, late TNM staging, high Edmondson-Steiner grading, and blood transfusion was associated with worsened prognosis. Of them, Edmondson-Steiner grading was identified as the sole independent prognostic factor for both overall and disease-free survival by multivariate analysis, whereas blood transfusion and the presence of PVTT independently predicted unfavorable overall or disease-free survival, respectively. Conclusions These data indicated that RMH was safe and appeared to be effective in treating cirrhotic patients with HCC. Some tumor-related and clinical variables influenced long-term outcome of these patients after RMH.
引用
收藏
页码:1782 / 1787
页数:6
相关论文
共 50 条
  • [41] Risk Factors for Hepatocellular Carcinoma After Splenectomy in Liver Cirrhotic Patients
    Honmyo, Naruhiko
    Kobayashi, Tsuyoshi
    Kuroda, Shintaro
    Ide, Kentaro
    Ohira, Masahiro
    Tahara, Hiroyuki
    Morimoto, Hiroshi
    Tanimine, Naoki
    Hamaoka, Michinori
    Yamaguchi, Megumi
    Yamamoto, Masateru
    Takei, Daisuke
    Aikata, Hiroshi
    Chayama, Kazuaki
    Ohdan, Hideki
    AMERICAN SURGEON, 2023, 89 (04) : 769 - 777
  • [42] An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy
    Tokumitsu, Yukio
    Tamesa, Takao
    Matsukuma, Satoshi
    Hashimoto, Noriaki
    Maeda, Yoshinari
    Tokuhisa, Yoshihiro
    Sakamoto, Kazuhiko
    Ueno, Tomio
    Hazama, Shoichi
    Ogihara, Hiroyuki
    Fujita, Yusuke
    Hamamoto, Yoshihiko
    Oka, Masaaki
    Iizuka, Norio
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (03) : 944 - 952
  • [43] Prognostic value of systemic inflammation score in patients with hepatocellular carcinoma after hepatectomy
    Shi, Shiming
    Chen, Qing
    Ye, Luxi
    Yin, Dan
    Li, Xuedong
    Dai, Zhi
    He, Jian
    ONCOTARGET, 2017, 8 (45) : 79366 - 79375
  • [44] EVI5 is a novel independent prognostic predictor in hepatocellular carcinoma after radical hepatectomy
    Tang, Jintian
    Ou, Jianghua
    Xu, Chunyan
    Yi, Chao
    Xue, Feng
    Xu, Lin
    Lai, Fenju
    Tang, Jianjun
    Li, Shengping
    Kang, Tiebang
    Ding, Wei
    Wang, Boqing
    ONCOLOGY REPORTS, 2017, 38 (04) : 2251 - 2258
  • [45] Prognostic nomograms and risk classifications of outcomes in very early-stage hepatocellular carcinoma patients after hepatectomy
    Feng, Long-Hai
    Sun, Hui-Chuan
    Zhu, Xiao-Dong
    Liu, Xue-Feng
    Zhang, Shi-Zhe
    Li, Xiao-Long
    Li, Yan
    Tang, Zhao-You
    EJSO, 2021, 47 (03): : 681 - 689
  • [46] Poor Prognostic Factors after Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma in the Modern Era
    Tsujita, Eiji
    Yamashita, Yo-Ichi
    Takeishi, Kazuki
    Matsuyama, Ayumi
    Tsutsui, Shin-Ichi
    Matsuda, Hiroyuki
    Toshima, Takeo
    Taketomi, Akinobu
    Shirabe, Ken
    Ishida, Teruyoshi
    Maehara, Yoshihiko
    AMERICAN SURGEON, 2012, 78 (04) : 419 - 425
  • [47] A new surgical strategy for cirrhotic patients with hepatocellular carcinoma and hypersplenismPerforming a hepatectomy after a laparoscopic splenectomy
    M. Shimada
    M. Hashizume
    K. Shirabe
    K. Takenaka
    K. Sugimachi
    Surgical Endoscopy, 2000, 14 : 127 - 130
  • [48] Analysis of Prognostic Factors for Survival after Hepatectomy for Hepatocellular Carcinoma Based on a Bayesian Network
    Cai, Zhi-qiang
    Si, Shu-bin
    Chen, Chen
    Zhao, Yaling
    Ma, Yong-yi
    Wang, Lin
    Geng, Zhi-min
    PLOS ONE, 2015, 10 (03):
  • [49] Risk factors for major morbidity after hepatectomy for hepatocellular carcinoma in 293 recent cases
    Sadamori, Hiroshi
    Yagi, Takahito
    Matsuda, Hiroaki
    Shinoura, Susumu
    Umeda, Yuzo
    Yoshida, Ryuichi
    Satoh, Daisuke
    Utsumi, Takasi
    Ohnishi, Teppei
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2010, 17 (05) : 709 - 718
  • [50] Prognostic Value of Repeat Hepatectomy for Hepatocellular Carcinoma Patients
    Nanashima, Atsushi
    Tanoue, Yukinori
    Hiyoshi, Masahide
    Imamura, Naoya
    Yano, Koichi
    Hamada, Takeomi
    Kitamura, Eiji
    Kai, Kengo
    Tahira, Kousei
    Nagayasu, Takeshi
    ANTICANCER RESEARCH, 2022, 42 (09) : 4553 - 4561